Inventor · disambiguated record
Sarah Jacqueline Perlmutter
Also filed as: PERLMUTTER SARAH J · PERLMUTTER SARAH JACQUELINE
12 granted patents·1 pending application·90 citations·filing 2015–2023
91Inventor score
Top patents by PatentIndex Score
13 records- 0197US10435438B2Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2019·Granted Oct 8, 2019·12 cites·21 claims
- 0297US10106579B2Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2015·Granted Oct 23, 2018·19 cites·20 claims
- 0396US10208089B2Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2018·Granted Feb 19, 2019·12 cites·21 claims
- 0495US10328115B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2018·Granted Jun 25, 2019·15 cites·22 claims
- 0594US11014965B2Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2020·Granted May 25, 2021·3 cites·18 claims
- 0694US10588936B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2019·Granted Mar 17, 2020·13 cites·20 claims
- 0794US9937222B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2016·Granted Apr 10, 2018·14 cites·15 claims
- 0891US10918691B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2020·Granted Feb 16, 2021·2 cites·21 claims
- 0987US12239684B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2023·Granted Mar 4, 2025·0 cites·13 claims
- 1082US11535650B1Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2022·Granted Dec 27, 2022·0 cites·2 claims
- 1178US11965040B2Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2021·Granted Apr 23, 2024·0 cites·12 claims
- 1275US11707503B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2021·Granted Jul 25, 2023·0 cites·20 claims
- 1359US2024158368A1Pyrrolidine Main Protease Inhibitors as Antiviral AgentsABBVIE INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sarah Jacqueline Perlmutter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →